These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Mitigated presentation of the neuroleptic malignant syndrome]. Grandiek M; Ramlal AD; Blom JD Tijdschr Psychiatr; 2014; 56(2):114-7. PubMed ID: 24535768 [TBL] [Abstract][Full Text] [Related]
46. [Catatonic syndrome and neuroleptic malignant syndrome]. Ruzikowska A Psychiatr Pol; 1999; 33(3):415-25. PubMed ID: 10786241 [TBL] [Abstract][Full Text] [Related]
47. Lethal catatonia. Ljubisavljevic V Aust N Z J Psychiatry; 2002 Aug; 36(4):563-4. PubMed ID: 12169165 [No Abstract] [Full Text] [Related]
48. What clinical analysis of antipsychotic-induced catatonia and neuroleptic malignant syndrome tells us about the links between these two syndromes: A systematic review. Virolle J; Redon M; Montastruc F; Taïb S; Revet A; Zivkovic V; Da Costa J; Very E Schizophr Res; 2023 Dec; 262():184-200. PubMed ID: 37599139 [TBL] [Abstract][Full Text] [Related]
49. The neuroleptic malignant syndrome and its differentiation from lethal catatonia. Fleischhacker WW; Unterweger B; Kane JM; Hinterhuber H Acta Psychiatr Scand; 1990 Jan; 81(1):3-5. PubMed ID: 2184638 [TBL] [Abstract][Full Text] [Related]
50. Catatonia is a risk factor for neuroleptic malignant syndrome. Carroll BT; Lee JW J Clin Psychiatry; 2004 Dec; 65(12):1722-3. PubMed ID: 15641881 [No Abstract] [Full Text] [Related]
51. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome. Addonizio G; Susman VL J Clin Psychiatry; 1987 Mar; 48(3):102-5. PubMed ID: 2880837 [TBL] [Abstract][Full Text] [Related]
52. Neuroleptic malignant syndrome and the catatonic dilemma. Caroff SN; Mann SC; Campbell EC Psychopharmacology (Berl); 2015 Feb; 232(3):661-2. PubMed ID: 25589146 [No Abstract] [Full Text] [Related]
53. Catatonia and NMS. Tan TK; Ong SH Br J Psychiatry; 1991 Jun; 158():858-9. PubMed ID: 1678667 [No Abstract] [Full Text] [Related]
59. Lethal catatonia complicated by the development of neuroleptic malignant syndrome in a middle-aged female. Goeke JE; Hagan DS; Goelzer SL; Coursin DB Crit Care Med; 1991 Nov; 19(11):1445-8. PubMed ID: 1935167 [No Abstract] [Full Text] [Related]